codeine phosphate 2 MG/ML / phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution

RxCUI
1661319
RxNorm name
codeine phosphate 2 MG/ML / phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution
Display name
Codeine/Phenylephrine/Triprolidine (Oral Liquid)
Full name
codeine phosphate 2 MG/ML / phenylephrine hydrochloride 2 MG/ML / triprolidine hydrochloride 0.5 MG/ML Oral Solution
Term type
SCD
Status
Active
Strength
10-10-2.5 mg/5ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-10-20 20:49:55

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092015
Active start
092015
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
triprolidine hydrochloride0.5 MG / 1 MLtriprolidinetriprolidine hydrochloride
codeine phosphate2 MG / 1 MLcodeinecodeine phosphate
phenylephrine hydrochloride2 MG / 1 MLphenylephrinephenylephrine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triprolidine10849
codeine2670
phenylephrine8163

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
28595025016rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
d5919b31-8191-4827-90d4-7782dcf539a0HISTEX™ AC SyrupAllegis Pharmaceuticals, LLC20190815

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01CAAdrenergic and dopaminergic agentsATC1-4phenylephrine
ATCR05DAOpium alkaloids and derivativesATC1-4codeine
ATCC05AXOther agents for treatment of hemorrhoids and anal fissures for topical useATC1-4phenylephrine
ATCR06AXOther antihistamines for systemic useATC1-4triprolidine
ATCR01BASympathomimeticsATC1-4phenylephrine
ATCS01FBSympathomimetics excl. antiglaucoma preparationsATC1-4phenylephrine
ATCS01GASympathomimetics used as decongestantsATC1-4phenylephrine
ATCR01ABSympathomimetics, combinations excl. corticosteroidsATC1-4phenylephrine
ATCR01AASympathomimetics, plainATC1-4phenylephrine
FDASPLN0000186105alpha-1 Adrenergic AgonistEPChas_epcphenylephrine
MEDRTD003061CodeineCHEMhas_ingredientcodeine phosphate
MEDRTD003061CodeineCHEMhas_ingredientcodeine
MEDRTD009020MorphineCHEMhas_active_metabolitescodeine phosphate
MEDRTD009020MorphineCHEMhas_active_metabolitescodeine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine hydrochloride
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine hydrochloride
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine
MEDRTD014311TriprolidineCHEMhas_ingredienttriprolidine hydrochloride
MEDRTD014311TriprolidineCHEMhas_ingredienttriprolidine
MEDRTD001249AsthmaDISEASEci_withcodeine
MEDRTD001249AsthmaDISEASEci_withcodeine phosphate
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treattriprolidine hydrochloride
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treattriprolidine
MEDRTD003327Coronary DiseaseDISEASEci_withtriprolidine
MEDRTD003327Coronary DiseaseDISEASEci_withtriprolidine hydrochloride
MEDRTD003371CoughDISEASEmay_treatcodeine
MEDRTD003371CoughDISEASEmay_treatcodeine phosphate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriprolidine
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriprolidine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine
MEDRTD004342Drug HypersensitivityDISEASEci_withcodeine
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withtriprolidine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withtriprolidine
MEDRTD004342Drug HypersensitivityDISEASEci_withcodeine phosphate
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine
MEDRTD006973HypertensionDISEASEci_withphenylephrine
MEDRTD006973HypertensionDISEASEci_withphenylephrine hydrochloride
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine hydrochloride
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine
MEDRTD007415Intestinal ObstructionDISEASEci_withcodeine
MEDRTD007415Intestinal ObstructionDISEASEci_withcodeine phosphate
MEDRTD015878MydriasisDISEASEinducesphenylephrine
MEDRTD015878MydriasisDISEASEinducesphenylephrine hydrochloride
MEDRTD010146PainDISEASEmay_treatcodeine
MEDRTD010146PainDISEASEmay_treatcodeine phosphate
MEDRTD011247PregnancyDISEASEci_withcodeine
MEDRTD011247PregnancyDISEASEci_withcodeine phosphate
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012131Respiratory InsufficiencyDISEASEci_withcodeine phosphate
MEDRTD012131Respiratory InsufficiencyDISEASEci_withcodeine
MEDRTD012220RhinitisDISEASEmay_treattriprolidine
MEDRTD012220RhinitisDISEASEmay_treattriprolidine hydrochloride
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine hydrochloride
MEDRTN0000175684Full Opioid AgonistsMOAhas_moacodeine
MEDRTN0000175684Full Opioid AgonistsMOAhas_moacodeine phosphate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moatriprolidine hydrochloride
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moatriprolidine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacodeine phosphate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacodeine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moatriprolidine hydrochloride
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moatriprolidine
MEDRTN0000175439AnalgesiaPEhas_pecodeine phosphate
MEDRTN0000175439AnalgesiaPEhas_pecodeine
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine hydrochloride
MEDRTN0000008657Decreased Histamine ActivityPEhas_petriprolidine hydrochloride
MEDRTN0000008657Decreased Histamine ActivityPEhas_petriprolidine
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pecodeine
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pecodeine phosphate
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine hydrochloride
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pecodeine phosphate
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pecodeine
MEDRTN0000000026Hepatic MetabolismPKhas_pkcodeine phosphate
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismcodeine phosphate
MEDRTN0000000026Hepatic MetabolismPKhas_pkcodeine
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismcodeine
MEDRTN0000000042Renal ExcretionPKhas_pkcodeine phosphate
MEDRTN0000000042Renal ExcretionPKhas_pkcodeine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH2 MG/ML / 2 MG/ML / 0.5 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE5
CODESVUID4034795
NAMESPrescribable Synonymcodeine phosphate 10 MG / phenylephrine HCl 10 MG / triprolidine HCl 2.5 MG in 5 mL Oral Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File